JP2010521442A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010521442A5 JP2010521442A5 JP2009553196A JP2009553196A JP2010521442A5 JP 2010521442 A5 JP2010521442 A5 JP 2010521442A5 JP 2009553196 A JP2009553196 A JP 2009553196A JP 2009553196 A JP2009553196 A JP 2009553196A JP 2010521442 A5 JP2010521442 A5 JP 2010521442A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- composition
- nsaid
- glycol ether
- ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0704846.5A GB0704846D0 (en) | 2007-03-13 | 2007-03-13 | Topical pharmaceutical formulation |
| PCT/GB2008/000540 WO2008110741A2 (en) | 2007-03-13 | 2008-02-15 | Topical pharmaceutical formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010521442A JP2010521442A (ja) | 2010-06-24 |
| JP2010521442A5 true JP2010521442A5 (enExample) | 2011-04-14 |
Family
ID=37988913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009553196A Pending JP2010521442A (ja) | 2007-03-13 | 2008-02-15 | 局所製剤処方 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8541470B2 (enExample) |
| EP (2) | EP2452671A2 (enExample) |
| JP (1) | JP2010521442A (enExample) |
| CN (1) | CN101663022A (enExample) |
| AU (1) | AU2008224735B2 (enExample) |
| BR (1) | BRPI0808887A2 (enExample) |
| CA (1) | CA2680074C (enExample) |
| CO (1) | CO6220926A2 (enExample) |
| DK (1) | DK2131813T3 (enExample) |
| ES (1) | ES2391914T3 (enExample) |
| GB (1) | GB0704846D0 (enExample) |
| MX (1) | MX2009009758A (enExample) |
| MY (1) | MY149545A (enExample) |
| NZ (1) | NZ579895A (enExample) |
| PL (1) | PL2131813T3 (enExample) |
| PT (1) | PT2131813E (enExample) |
| RU (1) | RU2468794C2 (enExample) |
| SG (1) | SG179480A1 (enExample) |
| TW (1) | TWI367110B (enExample) |
| UA (1) | UA100509C2 (enExample) |
| WO (1) | WO2008110741A2 (enExample) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3300721B2 (en) * | 2003-11-20 | 2025-01-08 | Novo Nordisk A/S | Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices |
| SG10201703086VA (en) | 2008-10-17 | 2017-05-30 | Xenon Pharmaceuticals Inc | Spiro-oxindole compounds and their use as therapeutic agents |
| AR077252A1 (es) | 2009-06-29 | 2011-08-10 | Xenon Pharmaceuticals Inc | Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos |
| JP5752136B2 (ja) | 2009-10-14 | 2015-07-22 | ゼノン・ファーマシューティカルズ・インコーポレイテッドＸｅｎｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． | スピロ−オキシインドール化合物のための合成方法 |
| CN105726531A (zh) | 2010-02-26 | 2016-07-06 | 泽农医药公司 | 用于局部给药的螺-羟吲哚化合物的药物组合物及其作为治疗剂的用途 |
| US11730709B2 (en) | 2010-10-29 | 2023-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
| US10695432B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
| US9504664B2 (en) | 2010-10-29 | 2016-11-29 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
| US8895537B2 (en) | 2010-10-29 | 2014-11-25 | Infirst Healthcare Ltd. | Compositions and methods for treating cardiovascular diseases |
| US11202831B2 (en) | 2010-10-29 | 2021-12-21 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
| US9308213B2 (en) | 2010-10-29 | 2016-04-12 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
| US11224659B2 (en) | 2010-10-29 | 2022-01-18 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
| US9271950B2 (en) | 2010-10-29 | 2016-03-01 | Infirst Healthcare Limited | Compositions for treating chronic inflammation and inflammatory diseases |
| US9744132B2 (en) | 2010-10-29 | 2017-08-29 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
| US9737500B2 (en) | 2010-10-29 | 2017-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
| US10695431B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
| AU2013246485A1 (en) | 2012-04-12 | 2014-10-16 | Xenon Pharmaceuticals Inc. | Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents |
| PL3795141T3 (pl) * | 2013-01-14 | 2025-11-12 | Infirst Healthcare Limited | Kompozycje w postaci roztworu stałego |
| EP2943183A1 (en) * | 2013-01-14 | 2015-11-18 | InFirst Healthcare Limited | Compositions and methods for treating severe pain |
| HK1218621A1 (zh) * | 2013-02-04 | 2017-03-03 | Infirst Healthcare Limited | 用於治疗慢性炎症和炎性疾病的组合物及方法 |
| US9012402B1 (en) | 2014-06-11 | 2015-04-21 | James Blanchard | Gel for topical delivery of NSAIDs to provide relief of musculoskeletal pain and methods for its preparation |
| US11007161B1 (en) | 2014-12-31 | 2021-05-18 | Eric Morrison | Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films |
| US10561627B2 (en) | 2014-12-31 | 2020-02-18 | Eric Morrison | Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films |
| US10596117B1 (en) | 2014-12-31 | 2020-03-24 | Eric Morrison | Lipoleosomes as carriers for aromatic amide anesthetic compounds |
| TW201636017A (zh) | 2015-02-05 | 2016-10-16 | 梯瓦製藥國際有限責任公司 | 以螺吲哚酮化合物之局部調配物治療帶狀疱疹後遺神經痛之方法 |
| GB201502845D0 (en) * | 2015-02-20 | 2015-04-08 | Futura Medical Dev Ltd | Topical pharmaceutical formulation |
| FR3041534B1 (fr) * | 2015-09-30 | 2019-03-15 | Vetoquinol Sa | Composition de nettoyant auriculaire |
| GB201609968D0 (en) * | 2016-06-07 | 2016-07-20 | Futura Medical Dev Ltd | Topical pharmaceutical formulation |
| US10100060B2 (en) | 2016-06-16 | 2018-10-16 | Xenon Pharmaceuticals Inc. | Asymmetric synthesis of funapide |
| WO2018163176A1 (en) * | 2017-03-07 | 2018-09-13 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd | Topical delivery systems for active compounds |
| US10821075B1 (en) | 2017-07-12 | 2020-11-03 | James Blanchard | Compositions for topical application of a medicaments onto a mammalian body surface |
| CN118903386A (zh) | 2017-08-24 | 2024-11-08 | 诺和诺德股份有限公司 | Glp-1组合物及其用途 |
| KR20220143036A (ko) | 2020-02-18 | 2022-10-24 | 노보 노르디스크 에이/에스 | 약학적 제형 |
| GB2596286B (en) | 2020-06-20 | 2023-01-25 | Francis Davis Adrian | Adherence to topical therapy |
| EP4188325A1 (en) | 2020-07-27 | 2023-06-07 | Incanthera R&D Ltd. | Topical formulation |
| GB2597526A (en) | 2020-07-27 | 2022-02-02 | Incanthera R&D Ltd | Topical formulation |
| GB202012836D0 (en) | 2020-08-17 | 2020-09-30 | Futura Medical Developments Ltd | Topical composition |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06104624B2 (ja) * | 1986-05-07 | 1994-12-21 | 太郎 小木曽 | 経皮吸収剤 |
| PE20011092A1 (es) | 2000-02-14 | 2001-11-12 | Procter & Gamble | Composiciones para el suministro topico de un agente farmaceuticamente activo que tiene reducida irritacion de la piel |
| DE10019171A1 (de) * | 2000-04-07 | 2001-10-18 | Schering Ag | Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe |
| PE20040321A1 (es) * | 2002-08-22 | 2004-07-15 | Novartis Consumer Health Sa | Composicion topica que comprende diclofenaco |
| US7132452B2 (en) * | 2003-03-10 | 2006-11-07 | Fang-Yu Lee | Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection |
| US20050137164A1 (en) * | 2003-09-22 | 2005-06-23 | Moshe Arkin | Diclofenac compositions for the treatment of skin disorders |
| EP1588697A1 (en) | 2004-04-16 | 2005-10-26 | Kurt H. Prof. Dr. Bauer | Emulsion gel for topical application of pharmaceuticals |
| US20050244522A1 (en) | 2004-04-30 | 2005-11-03 | Carrara Dario Norberto R | Permeation enhancer comprising genus Curcuma or germacrone for transdermal and topical administration of active agents |
-
2007
- 2007-03-13 GB GBGB0704846.5A patent/GB0704846D0/en not_active Ceased
-
2008
- 2008-02-15 DK DK08709428.0T patent/DK2131813T3/da active
- 2008-02-15 ES ES08709428T patent/ES2391914T3/es active Active
- 2008-02-15 MY MYPI20093774A patent/MY149545A/en unknown
- 2008-02-15 WO PCT/GB2008/000540 patent/WO2008110741A2/en not_active Ceased
- 2008-02-15 NZ NZ579895A patent/NZ579895A/en not_active IP Right Cessation
- 2008-02-15 EP EP12154983A patent/EP2452671A2/en not_active Withdrawn
- 2008-02-15 UA UAA200910111A patent/UA100509C2/ru unknown
- 2008-02-15 PL PL08709428T patent/PL2131813T3/pl unknown
- 2008-02-15 PT PT08709428T patent/PT2131813E/pt unknown
- 2008-02-15 SG SG2012017497A patent/SG179480A1/en unknown
- 2008-02-15 JP JP2009553196A patent/JP2010521442A/ja active Pending
- 2008-02-15 EP EP08709428A patent/EP2131813B1/en not_active Not-in-force
- 2008-02-15 RU RU2009136228/15A patent/RU2468794C2/ru active
- 2008-02-15 CA CA2680074A patent/CA2680074C/en active Active
- 2008-02-15 MX MX2009009758A patent/MX2009009758A/es active IP Right Grant
- 2008-02-15 CN CN200880007936A patent/CN101663022A/zh active Pending
- 2008-02-15 US US12/530,960 patent/US8541470B2/en active Active
- 2008-02-15 BR BRPI0808887-0A patent/BRPI0808887A2/pt not_active Application Discontinuation
- 2008-02-15 AU AU2008224735A patent/AU2008224735B2/en not_active Ceased
- 2008-02-20 TW TW097105840A patent/TWI367110B/zh not_active IP Right Cessation
-
2009
- 2009-10-08 CO CO09111579A patent/CO6220926A2/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010521442A5 (enExample) | ||
| RU2009136228A (ru) | Фармацевтическая композиция для топического применения | |
| JP5734479B2 (ja) | ジクロフェナクの新規な非水性外用溶液およびそれを調製するためのプロセス | |
| JP2015527386A5 (enExample) | ||
| JP2010513500A5 (enExample) | ||
| RU2012137785A (ru) | Лечение респираторных заболеваний | |
| CA2768586A1 (en) | Dermal formulations of dp2 receptor antagonists | |
| JP2008540394A5 (enExample) | ||
| JP2016508158A5 (enExample) | ||
| JP2014185132A5 (enExample) | ||
| RS53887B1 (sr) | Jedinjenje sa topikalnom primenom za aktinične keratoze | |
| JP2014509655A5 (enExample) | ||
| JP2013515020A5 (enExample) | ||
| ES2452872T3 (es) | Composición farmacéutica que comprende una mezcla solvente y un derivado o análogo de vitamina D | |
| CN108025078A (zh) | 用于nsaid的固体溶液组合物 | |
| JP7438566B2 (ja) | 貼付剤 | |
| NZ598554A (en) | Pharmaceutical compositions and method for treating inflammation in cattle and other animals | |
| AR072223A1 (es) | Composiciones transdermicas farmaceuticas y metodo para tratar la inflamacion en el ganado vacuno | |
| JP2016501205A5 (enExample) | ||
| JP2014224110A (ja) | ロキソプロフェン含有外用剤組成物 | |
| JP2014515407A5 (enExample) | ||
| JP2018505905A (ja) | 局所医薬製剤 | |
| JP5642658B2 (ja) | 非水性貼付剤 | |
| WO2014091729A1 (ja) | 基剤、及び皮膚外用剤 | |
| JP2008522972A5 (enExample) |